![George Hodgin](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Perfil
George Bennett Hodgin has founded a company called Biopharmaceutical Research Co. in 2017, where he currently holds the title of Chief Executive Officer & Director.
Cargos activos de George Hodgin
Empresas | Cargo | Inicio |
---|---|---|
Biopharmaceutical Research Co.
![]() Biopharmaceutical Research Co. Pharmaceuticals: OtherHealth Technology Biopharmaceutical Research Co. is a specialty pharmaceutical company that focuses on providing safe and effective options for treating patients with innovative cannabinoid therapeutics. The company is based in Castroville, CA. The company holds several DEA registrations across the entire value chain of cannabis and is pioneering the federally legal cannabis space in the USA. BRC has full DEA compliance for botanically derived cannabinoids and has developed proprietary poly-cannabinoids in titratable dosages that are soon to enter the clinic. The company was founded in 2017 by George Bennett Hodgin, who has been the CEO since 2017. | Fundador | 01/01/2017 |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 1 |
---|---|
Biopharmaceutical Research Co.
![]() Biopharmaceutical Research Co. Pharmaceuticals: OtherHealth Technology Biopharmaceutical Research Co. is a specialty pharmaceutical company that focuses on providing safe and effective options for treating patients with innovative cannabinoid therapeutics. The company is based in Castroville, CA. The company holds several DEA registrations across the entire value chain of cannabis and is pioneering the federally legal cannabis space in the USA. BRC has full DEA compliance for botanically derived cannabinoids and has developed proprietary poly-cannabinoids in titratable dosages that are soon to enter the clinic. The company was founded in 2017 by George Bennett Hodgin, who has been the CEO since 2017. | Health Technology |
- Bolsa de valores
- Insiders
- George Hodgin